Clinical Trial Update: Bendamustine Hydrochloride Injection for Initial Treatment of Chronic Lymphocytic Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating bendamustine hydrochloride injection as initial therapy for chronic lymphocytic leukemia has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Bendamustine hydrochloride injection (bendamustine hydrochloride)

Snippet

Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd. | Conditions: Chronic Lymphocytic Leukemia | Phase 2 | Status: COMPLETED